Different effects of antihypertensive agents on cardiac and vascular hypertrophy in the transgenic rat line TGR(mRen2)27

American Journal of Hypertension

Volumn 12, Issue 7, 1999, Pages 724-731

  Brosnan, M Julia ^a   Devlin, Alison M ^a   Clark, James S ^a   Mullins, John J ^b   Dominiczak, Anna F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Centre for Genome Research   (United Kingdom)

Author keywords

Hydralazine; Hypertension; Perindopril; Polyploidy; Transgenic rat

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROCHLOROTHIAZIDE; PERINDOPRIL; RENIN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL WALL; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; GENDER; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; PATHOGENESIS; POLYPLOIDY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC ANIMAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; AORTIC DISEASES; CARDIOMEGALY; CELL CYCLE; DNA; DRUG THERAPY, COMBINATION; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HEART VENTRICLES; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYPERTENSION; HYPERTROPHY; INDOLES; MALE; MUSCLE, SMOOTH, VASCULAR; PERINDOPRIL; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; TRANSGENES;

EID: 0033031607     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00021-7     Document Type: Article

References (34)

1. Kannel W.B., Abbott R.D. A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognised myocardial infarction the Framingham Study . Am Heart J. 111:1986;391-397.
2. Owens G.K., Schwartz S.M. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat role of cellular hypertrophy, hyperploidy and hyperplasia . Circ Res. 51:1982;280-289.
3. Olivetti G., Melissari M., Marchetti G., Anversa P. Quantitative structural changes of the rat thoracic aorta in early spontaneous hypertension. Tissue composition, and hypertrophy and hyperplasia of smooth muscle cells. Circ Res. 51:1982;19-26.
4. Devlin A.M., Gordon J.F., Davidson A.O., et al. The effects of perindopril on vascular smooth muscle polyploidy in stroke prone spontaneously hypertensive rats. J Hypertens. 13:1995;211-218.
5. Devlin A.M., Davidson A.O., Gordon J.F., et al. Vascular smooth muscle polyploidy in genetic hypertension the role of angiotensin II . J Hum. Hypertens. 9:1995;497-500.
6. Owens G.K. Influence of blood pressure on development of aortic smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension. 9:1987;178-187.
7. Simon A.C., Safar M.E., Levenson J.A., et al. An evaluation of large arteries compliance in man. Am J Physiol. 5:1979;H550-H554.
8. Safar M.E., Simon A.C., Levenson J.A. Structural changes of large arteries in sustained essential hypertension. Hypertension. 6:(suppl III):1984;III117-III121.
9. Conyers R.B., Kwan C.-Y., Lee R.M.K.W. Alterations in β-adrenoceptors and polyploidy in cultured aortic smooth muscle cells from different age groups of spontaneously hypertensive rats and Wistar-Kyoto rats. J Hypertens. 13:1995;507-515.
10. Dominiczak A.F., Devlin A.M., Lee W.K., et al. Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension. Hypertension. 27:1996;752-759.
11. Devlin A.M., Brosnan M.J., Graham D., et al. Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo. Am J Physiol. 274:1998;H52-H59.
12. Brilla C.G., Pick R., Tan L.B., et al. Remodelling of the rat right and left ventricles in experimental hypertension. Circ Res. 67:1990;1355-1364.
13. Brilla C.G., Maisch B., Weber W.T. Renin-angiotensin system and myocardial collagen matrix remodelling in hypertensive heart disease in vivo and in vitro studies on collagen matrix regulation . J Clin Invest. 71:1993;S35-S41.
14. Stouffer G.A., Owens G.K. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β Circ Res. 70:1992;820-828.
15. 2+ mobilization and protein kinase C activation. J Biol Chem. 264:1989;526-530.
16. Dominiczak A.F., Devlin A.M., Brosnan M.J., et al. Left ventricular hypertrophy and arterial blood pressure in experimental models of hypertension. Adv Exp Med Biol. 432:1997;23-33.
17. Black M.J., Adams M.A., Bobik A., et al. Effect of enalapril on aortic smooth muscle cell polyploidy in the spontaneously hypertensive rat. J Hypertens. 7:1989;997-1003.
18. Mullins J.J., Peters J., Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 344:1990;541-544.
19. Barrett G.L., Mullins J.J. Studies on blood pressure regulation in transgenic hypertensive ren-2 transgenic rats. Kidney Intern. (suppl 37):1992;S125-S128.
20. 1 blockade in mRen2 transgenic rats. J Cardiovasc Pharmacol. 27:1996;476-478.
21. Zolk O., Flesch M., Schnabel P., et al. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and β-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats. Brit J Pharmacol. 123:1998;405-412.
22. Davidson A.O., Schork N., Jacques B.C., et al. Blood pressure in genetically hypertensive rats influence of the Y chromosome . Hypertension. 26:1995;452-459.
23. Vindelov L.L., Christensen I.J., Nissen N.I. A detergent trypsin method of preparation of nuclei for flow cytometric DNA analysis. Cytometry. 3:1983;323-327.
24. Morton J.J., Wallace E.C.H. The importance of the renin angiotensin system in the development and maintenance of hypertension in the two kidney one clip hypertensive rat. Clin Sci. 64:1983;359-370.
25. Morton J.J., Webb D.J. Measurement of plasma angiotensin II. Clin Sci. 68:1985;483-484.
26. Owens G.K., Schwartz S.M. Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res. 53:1983;491-501.
27. Lichenstein A.H., Brecher P., Chobanian A.V. Effects of deoxycorticosterone-salt hypertension on cell ploidy in the rat aorta. Hypertension. 8:(suppl II):1986;II50-II54.
28. Lee M.A., Bohm M., Kim S., et al. Differential gene expression of renin and angiotensinogen in the TGR(mREN2)27 transgenic rat. Hypertension. 25:1995;570-580.
29. Owens G.K. Differential effects of anti-hypertensive drug therapy on vascular smooth muscle cell hypertrophy and hyperplasia in the spontaneously hypertensive rat. Circ Res. 56:1985;525-536.
30. Dzau V.J., Gibbons G.H. Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol. 62:1988;30G-35G.
31. Owens G.K. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am J Physiol. 257:1989;H1755-H1765.
32. Itzhaki J.E., Gilbert C.S., Porter A.C.G. Construction by gene targetting in human cells of a conditional CDC2 mutant that rereplicates its DNA. Nature Genet. 15:1997;258-265.
33. Clark J.S., Jeffs B., Davidson A.O., et al. Quantitative trait loci in genetically hypertensive rats. Possible sex specificity. Hypertension. 28:1996;898-906.
34. Lee R.M.K.W., Tsoporis J., Wang R.R.J. Influence of chronic nadolol treatment on blood pressure and vascular changes in spontaneously hypertensive rats. Can J Physiol Pharmacol. 70:1992;1261-1270.